{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:33:32Z","timestamp":1777977212099,"version":"3.51.4"},"reference-count":73,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Before the onset of the coronavirus disease 2019 (COVID-19) pandemic, the African region already faced a substantial communicable disease burden and a rising prevalence of noncommunicable and chronic conditions. The COVID-19 pandemic has underscored critical vulnerabilities within the health systems in African countries and highlighted the urgent need for self-sufficiency to increase resilience in vaccine manufacturing and clinical trial capacity. In response, substantial efforts are underway to develop vaccine and pharmaceutical manufacturing capabilities across the continent. Ongoing initiatives supported by large donor organizations are aimed at initiating much-needed progress toward greater self-sufficiency in vaccine production in Africa, as coordinated by the Africa Centers for Disease Control. Continued investment, regulatory harmonization, and strengthened international and regional partnerships are essential for Africa to develop sustainable vaccine manufacturing.<\/jats:p>","DOI":"10.1093\/cid\/ciaf055","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T16:05:44Z","timestamp":1753200344000},"page":"S9-S15","source":"Crossref","is-referenced-by-count":5,"title":["Overcoming Vaccine Inequities and Research Gaps in Africa: Challenges and Opportunities Identified During the COVID-19 Pandemic"],"prefix":"10.1093","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0017-1377","authenticated-orcid":false,"given":"Cara Lynn","family":"Kim","sequence":"first","affiliation":[{"name":"International Vaccine Institute , Seoul ,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3137-0093","authenticated-orcid":false,"given":"Thaint Thaint","family":"Thwe","sequence":"additional","affiliation":[{"name":"International Vaccine Institute , Seoul ,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0429-4723","authenticated-orcid":false,"given":"Ligia M Cruz","family":"Espinoza","sequence":"additional","affiliation":[{"name":"International Vaccine Institute , Seoul ,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1761-328X","authenticated-orcid":false,"given":"Jonathan D","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"International Vaccine Institute , Seoul ,","place":["Republic of Korea"]},{"name":"Department of Epidemiology, University of Washington , Seattle, Washington ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mosoka P","family":"Fallah","sequence":"additional","affiliation":[{"name":"Research and Innovation, Africa Centers for Disease Control , Addis Ababa ,","place":["Ethiopia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyon Jin","family":"Jeon","sequence":"additional","affiliation":[{"name":"International Vaccine Institute , Seoul ,","place":["Republic of Korea"]},{"name":"Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus , Cambridge ,","place":["United Kingdom"]},{"name":"Madagascar Institute for Vaccine Research, University of Antananarivo , Antananarivo ,","place":["Madagascar"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rapha\u00ebl","family":"Rakotozandrindrainy","sequence":"additional","affiliation":[{"name":"Madagascar Institute for Vaccine Research, University of Antananarivo , Antananarivo ,","place":["Madagascar"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellis","family":"Owusu-Dabo","sequence":"additional","affiliation":[{"name":"School of Public Health, Kwame Nkrumah University of Science and Technology , Kumasi ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdramane Soura","family":"Bassiahi","sequence":"additional","affiliation":[{"name":"Institut Sup\u00e9rieur des Sciences de la Population , Universit\u00e9 Ouaga II, Ouagadougou ,","place":["Burkina Faso"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8820-3843","authenticated-orcid":false,"given":"Octavie","family":"Lunguya","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Institut National de Recherche Biom\u00e9dicale , Kinshasa ,","place":["Democratic Republic of the Congo"]},{"name":"Department of Medical Biology, Microbiology Service, University Teaching Hospital of Kinshasa, University of Kinshasa , Kinshasa ,","place":["Democratic Republic of the Congo"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6880-6655","authenticated-orcid":false,"given":"Ilesh V","family":"Jani","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Sa\u00fade , Maputo ,","place":["Mozambique"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6043-7170","authenticated-orcid":false,"given":"Florian","family":"Marks","sequence":"additional","affiliation":[{"name":"International Vaccine Institute , Seoul ,","place":["Republic of Korea"]},{"name":"Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus , Cambridge ,","place":["United Kingdom"]},{"name":"Madagascar Institute for Vaccine Research, University of Antananarivo , Antananarivo ,","place":["Madagascar"]},{"name":"Heidelberg Institute of Global Health, University of Heidelberg , Heidelberg ,","place":["Germany"]},{"name":"The Hong Kong Jockey Club Global Health Institute , Hong Kong Special Administrative Region ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4005-8605","authenticated-orcid":false,"given":"Birkneh Tilahun","family":"Tadesse","sequence":"additional","affiliation":[{"name":"International Vaccine Institute , Seoul ,","place":["Republic of Korea"]},{"name":"Heidelberg Institute of Global Health, University of Heidelberg , Heidelberg ,","place":["Germany"]},{"name":"Department of Global Public Health, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"2025072212053912500_ciaf055-B1","doi-asserted-by":"crossref","first-page":"e1375","DOI":"10.1016\/S2214-109X(19)30374-2","article-title":"Burden of non-communicable diseases in sub-Saharan Africa, 1990\u20132017: results from the global burden of disease study 2017","volume":"7","author":"Gouda","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2025072212053912500_ciaf055-B2","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1056\/NEJMp2008193","article-title":"Africa in the path of Covid-19","volume":"383","author":"El-Sadr","year":"2020","journal-title":"New Engl J Med"},{"key":"2025072212053912500_ciaf055-B3","author":"WHO Africa"},{"key":"2025072212053912500_ciaf055-B4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/vaccines12020168","article-title":"Status of routine immunization coverage in the World Health Organization African region three years into the COVID-19 pandemic","volume":"12","author":"Mboussou","year":"2024","journal-title":"Vaccines"},{"key":"2025072212053912500_ciaf055-B5","author":"The Global Fund"},{"key":"2025072212053912500_ciaf055-B6","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.4269\/ajtmh.21-0899","article-title":"Relative burdens of the COVID-19, malaria, tuberculosis, and HIV\/AIDS epidemics in sub-Saharan Africa","volume":"105","author":"Bell","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"2025072212053912500_ciaf055-B7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.34172\/hpp.2021.53","article-title":"The status of neglected tropical diseases amidst COVID-19 in Africa: current evidence and recommendations","volume":"11","author":"Akinokun","year":"2021","journal-title":"Health Promot Perspect"},{"key":"2025072212053912500_ciaf055-B8","volume-title":"Global report on neglected tropical diseases 2023","author":"World Health Organization.","year":"2023"},{"key":"2025072212053912500_ciaf055-B9","doi-asserted-by":"crossref","first-page":"6433","DOI":"10.1002\/jmv.27219","article-title":"Lassa fever amidst the COVID-19 pandemic in Africa: a rising concern, efforts, challenges, and future recommendations","volume":"93","author":"Uwishema","year":"2021","journal-title":"J Med Virol"},{"key":"2025072212053912500_ciaf055-B10","author":"World Health Organization"},{"key":"2025072212053912500_ciaf055-B11","doi-asserted-by":"crossref","first-page":"e1099","DOI":"10.1016\/S2214-109X(22)00233-9","article-title":"COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns","volume":"10","author":"Cabore","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2025072212053912500_ciaf055-B12","doi-asserted-by":"crossref","first-page":"e008793","DOI":"10.1136\/bmjgh-2022-008793","article-title":"SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021","volume":"7","author":"Lewis","year":"2022","journal-title":"BMJ Glob Health"},{"key":"2025072212053912500_ciaf055-B13","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(21)02796-3","article-title":"Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020\u201321","volume":"399","author":"Wang","year":"2022","journal-title":"Lancet"},{"key":"2025072212053912500_ciaf055-B14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41577-021-00579-y","article-title":"Understanding COVID-19 in Africa","volume":"21","author":"Tessema","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"2025072212053912500_ciaf055-B15","doi-asserted-by":"crossref","first-page":"8638","DOI":"10.3390\/ijerph18168638","article-title":"What could explain the lower COVID-19 burden in Africa despite considerable circulation of the SARS-CoV-2 virus?","volume":"18","author":"Wamai","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2025072212053912500_ciaf055-B16","volume-title":"Report on the strategic response to COVID-19 in the WHO African region, February to December 2020","author":"World Health Organization","year":"2021"},{"key":"2025072212053912500_ciaf055-B17","doi-asserted-by":"crossref","first-page":"e007179","DOI":"10.1136\/bmjgh-2021-007179","article-title":"The COVID-19 pandemic and healthcare systems in Africa: a scoping review of preparedness, impact and response","volume":"6","author":"Tessema","year":"2021","journal-title":"BMJ Glob Health"},{"key":"2025072212053912500_ciaf055-B18","doi-asserted-by":"crossref","first-page":"03085","DOI":"10.7189\/jogh.12.03085","article-title":"COVID-19 in Africa: supply chain disruptions and the role of the Africa continental free trade agreement","volume":"12","author":"Kamara","year":"2022","journal-title":"J Glob Health"},{"key":"2025072212053912500_ciaf055-B19","first-page":"22","article-title":"Two years of COVID-19 in Africa: lessons for the world","volume":"601","author":"Happi","year":"2022","journal-title":"Nature"},{"key":"2025072212053912500_ciaf055-B20","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/S0140-6736(21)01198-3","article-title":"Africa's need for more COVID-19 clinical trials","volume":"397","author":"Makoni","year":"2021","journal-title":"Lancet"},{"key":"2025072212053912500_ciaf055-B21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-3-031-19719-2_3","volume-title":"Healthcare and disease burden in Africa","author":"Niohuru","year":"2023"},{"key":"2025072212053912500_ciaf055-B22","author":"Africa Centres for Disease Control and Prevention"},{"key":"2025072212053912500_ciaf055-B23"},{"key":"2025072212053912500_ciaf055-B24","first-page":"S37","article-title":"Immunogenicity and Safety of Heterologous Versus Homologous Prime-Boost Regimens With BBIBP-CorV and Ad26.COV2.S COVID-19 Vaccines: A Multicentric, Randomized, Observer-Blinded Non-inferiority Trial in Madagascar and Mozambique","volume":"80","author":"Ramgi","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2025072212053912500_ciaf055-B25","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/cid\/ciaf093","article-title":"Real-world Evaluation of the Effectiveness of Sinopharm COVID-19 Vaccine Against Symptomatic COVID-19 in an Omicron-Dominant Setting in Mozambique: A Test-Negative, Case-Control Study","volume":"80","author":"Capitine","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2025072212053912500_ciaf055-B26","doi-asserted-by":"crossref","first-page":"e004059","DOI":"10.1136\/bmjgh-2020-004059","article-title":"Africa's contribution to the science of the COVID-19\/SARS-CoV-2 pandemic","volume":"6","author":"Kana","year":"2021","journal-title":"BMJ Glob Health"},{"key":"2025072212053912500_ciaf055-B27","doi-asserted-by":"crossref","first-page":"e005690","DOI":"10.1136\/bmjgh-2021-005690","article-title":"A bibliometric analysis of COVID-19 research in Africa","volume":"6","author":"Guleid","year":"2021","journal-title":"BMJ Glob Health"},{"key":"2025072212053912500_ciaf055-B28","author":"Wellcome Trust"},{"key":"2025072212053912500_ciaf055-B29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.17159\/sajs.2022\/13224","article-title":"Randomised trials of COVID-19 vaccines in Africa\u2014charting the path forward","volume":"118","author":"Wiysonge","year":"2022","journal-title":"S Afr J Sci"},{"key":"2025072212053912500_ciaf055-B30","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.2147\/IDR.S401074","article-title":"Safety and efficacy of COVID-19 vaccine in Africa: systematic review","volume":"16","author":"Mengstu","year":"2023","journal-title":"Infect Drug Resist"},{"key":"2025072212053912500_ciaf055-B31","first-page":"9","article-title":"Research output of the top 10 African countries: an analytical study","volume":"15","author":"Ali","year":"2021","journal-title":"COLLNET J Scientomet Inform Manage"},{"key":"2025072212053912500_ciaf055-B32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12961-021-00778-y","article-title":"Measuring health science research and development in Africa: mapping the available data","volume":"19","author":"Wenham","year":"2021","journal-title":"Health Res Policy Syst"},{"key":"2025072212053912500_ciaf055-B33","doi-asserted-by":"crossref","first-page":"010321","DOI":"10.7189\/jogh.10.010321","article-title":"From Africa to the world: reimagining Africa's research capacity and culture in the global knowledge economy","volume":"10","author":"Olufadewa","year":"2020","journal-title":"J Glob Health"},{"key":"2025072212053912500_ciaf055-B34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.12688\/openresafrica.14185.1","article-title":"Funding and COVID-19 research in Africa: two years on, are the research needs of Africa being met?","volume":"6","author":"Antonio","year":"2023","journal-title":"Open Res Afr"},{"key":"2025072212053912500_ciaf055-B35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1186\/s13063-021-05621-x","article-title":"COVID-19-related research in Africa: a cross-sectional review of the International Clinical Trial Registration Platform (ICTRP)","volume":"22","author":"Edem","year":"2021","journal-title":"Trials"},{"key":"2025072212053912500_ciaf055-B36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12939-018-0748-6","article-title":"Barriers for conducting clinical trials in developing countries\u2014a systematic review","volume":"17","author":"Alemayehu","year":"2018","journal-title":"Int J Equity Health"},{"key":"2025072212053912500_ciaf055-B37","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/14760584.2024.2395546","article-title":"Global pandemic preparedness: learning from the COVID-19 vaccine development and distribution","volume":"23","author":"Agampodi","year":"2024","journal-title":"Exp Rev Vaccines"},{"key":"2025072212053912500_ciaf055-B38","author":"World Health Organization"},{"key":"2025072212053912500_ciaf055-B39","author":"World Health Organization"},{"key":"2025072212053912500_ciaf055-B40","author":"World Health Organization"},{"key":"2025072212053912500_ciaf055-B41","author":"World Health Organization"},{"key":"2025072212053912500_ciaf055-B42","author":"World Health Organization"},{"key":"2025072212053912500_ciaf055-B43","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1186\/s12889-022-14016-9","article-title":"Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the kingdom of Morocco","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Public Health"},{"key":"2025072212053912500_ciaf055-B44","doi-asserted-by":"crossref","first-page":"182","DOI":"10.12688\/wellcomeopenres.19150.2","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1\/2 single-blind, randomised controlled trial","volume":"8","author":"Hamaluba","year":"2023","journal-title":"Wellcome Open Res"},{"key":"2025072212053912500_ciaf055-B45","author":"World Health Organization"},{"key":"2025072212053912500_ciaf055-B46","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","volume":"395","author":"Zhu","year":"2020","journal-title":"Lancet"},{"key":"2025072212053912500_ciaf055-B47","author":"Centers for Disease Control and Prevention"},{"key":"2025072212053912500_ciaf055-B48","author":"AlJazeera"},{"key":"2025072212053912500_ciaf055-B49","volume-title":"Updates on joint prevention and control mechanism for COVID-19","author":"The State Council of the People's Republic of China","year":"2021"},{"key":"2025072212053912500_ciaf055-B50","author":"World Health Organization"},{"key":"2025072212053912500_ciaf055-B51","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s41562-023-01615-8","article-title":"A panel dataset of COVID-19 vaccination policies in 185 countries","volume":"7","author":"Cameron-Blake","year":"2023","journal-title":"Nat Human Behav"},{"key":"2025072212053912500_ciaf055-B52","author":"CEPI"},{"key":"2025072212053912500_ciaf055-B53","author":"World Health Organization"},{"key":"2025072212053912500_ciaf055-B54","author":"Africa Centres for Disease Control and Prevention"},{"key":"2025072212053912500_ciaf055-B55","author":"Africa Centres for Disease Control and Prevention"},{"key":"2025072212053912500_ciaf055-B56","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/trstmh\/trac130","article-title":"COVID-19 vaccine equity in Africa","volume":"117","author":"Turyasingura","year":"2023","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2025072212053912500_ciaf055-B57","doi-asserted-by":"crossref","first-page":"307","DOI":"10.15585\/mmwr.mm7314a3","article-title":"COVID-19 vaccination coverage\u2014World Health Organization African Region, 2021\u20132023","volume":"73","author":"Doshi","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025072212053912500_ciaf055-B58","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3390\/vaccines11051010","article-title":"COVID-19 vaccination in the WHO African Region: progress made in 2022 and factors associated","volume":"11","author":"Mboussou","year":"2023","journal-title":"Vaccines"},{"key":"2025072212053912500_ciaf055-B59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s41182-023-00564-2","article-title":"Vaccine inequity: a threat to Africa's recovery from COVID-19","volume":"51","author":"Wei","year":"2023","journal-title":"Trop Med Health"},{"key":"2025072212053912500_ciaf055-B60","volume-title":"COVID-19 vaccination in the WHO African region. Monthly Bulletin Issue No. 10","author":"World Health Organization","year":"2022"},{"key":"2025072212053912500_ciaf055-B61","doi-asserted-by":"crossref","DOI":"10.1038\/d44148-022-00104-w","article-title":"Africa is successfully developing its own science initiatives","author":"Taylor-Robinson","year":"2022","journal-title":"Nat Africa"},{"key":"2025072212053912500_ciaf055-B62","doi-asserted-by":"crossref","first-page":"e1088","DOI":"10.1016\/S2214-109X(22)00243-1","article-title":"The African medicines agency: the key to unlocking clinical research in Africa","volume":"10","author":"Hwenda","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2025072212053912500_ciaf055-B63","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s40249-022-01040-5","article-title":"Sustainable strategies for Ebola virus disease outbreak preparedness in Africa: a case study on lessons learnt in countries neighbouring the Democratic Republic of the Congo","volume":"11","author":"Ryan","year":"2022","journal-title":"Infect Dis Poverty"},{"key":"2025072212053912500_ciaf055-B64","doi-asserted-by":"crossref","first-page":"659504","DOI":"10.3389\/fpubh.2021.659504","article-title":"Sustainable laboratory capacity building after the 2014 Ebola outbreak in the Republic of Guinea","volume":"9","author":"Ndjomou","year":"2021","journal-title":"Front Public Health"},{"key":"2025072212053912500_ciaf055-B65","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-021-01048-1","article-title":"How COVID spurred Africa to plot a vaccines revolution","author":"Irwin","year":"2021","journal-title":"Nature"},{"key":"2025072212053912500_ciaf055-B66","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/bmj.p908","article-title":"Vaccine manufacturing in Africa","volume":"381","author":"Alakija","year":"2023","journal-title":"BMJ"},{"key":"2025072212053912500_ciaf055-B67","author":"World Health Organization"},{"key":"2025072212053912500_ciaf055-B68","author":"BioNTECH"},{"key":"2025072212053912500_ciaf055-B69","author":"GAVI The Vaccine Alliance"},{"key":"2025072212053912500_ciaf055-B70","author":"Brown University School of Public Health"},{"key":"2025072212053912500_ciaf055-B71","author":"African Union"},{"key":"2025072212053912500_ciaf055-B72","doi-asserted-by":"crossref","first-page":"e13727","DOI":"10.1136\/bmjgh-2023-013727","article-title":"Regulatory approval of clinical trials: is it time to reinvent the wheel?","volume":"9","author":"Saleh","year":"2024","journal-title":"BMJ Global Health"},{"key":"2025072212053912500_ciaf055-B73","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1057\/s41271-023-00405-w","article-title":"A call to action: securing an uninterrupted supply of Africa's medical products and technologies post COVID-19","volume":"44","author":"Ejekam","year":"2023","journal-title":"J Public Health Policy"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/Supplement_1\/S9\/63819428\/ciaf055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/Supplement_1\/S9\/63819428\/ciaf055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T16:05:52Z","timestamp":1753200352000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/80\/Supplement_1\/S9\/8210484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,15]]},"references-count":73,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2025,7,22]]},"published-print":{"date-parts":[[2025,7,22]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf055","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6,15]]},"published":{"date-parts":[[2025,6,15]]}}}